Volume 19, Issue 1, January 2025

Index

INTRODUCTION

INTRODUCTION

Jacques De Greve


PRACTICE GUIDELINES

Prevention of chemotherapy-induced nausea and vomiting: Updated guidance from the BSMO supportive care task force

C. Fontaine, J. Collignon, P. Debruyne, L. Duck, E. Everaert, T. Feys, C. Langenaeken, F. Lebrun, J. Mebis, E. Naert, P. Van Landuyt, S. Wuyts, C. van Marcke de Lummen, F. Vanryckeghem, V. Verschaeve, J. Klaskersky


ONCOCASE

Therapy-related myeloid neoplasms with a focus on parp inhibitors: A case report

E. Van Haute, D. Schrijvers, R. Steinkamm, K. Beel, An Vandebroek


A case of sarcoid-like reaction in a patient with HER2-positive breast carcinoma treated with trastuzumab and pertuzumab

E. De Smet, D. Schrijvers, K. De Muynck, A. Vandebroek, E. De Droogh


Jaundice in a patient with renal cell carcinoma: Stauffer syndrome or not?

L. Naert, S. Proost, A. Driessen, T. Vandamme


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

J. Blokken